University of Münster
CRIS@UM
DE | EN

Dr. Catharina Korsukewitz

Current affiliations

Publications

Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab
Kleinschnitz C., Klotz L., Wiendl H., Scalfari A., Meuth S.G., Pfeuffer S., Ruck T., Pul R., Rolfes L., Korsukewitz C., Pawlitzki M., Wildemann B. (2021)
In: Journal of Neurology, Neurosurgery and Psychiatry, 92(9), 1007-1013. doi:10.1136/jnnp-2020-325304
Research article (journal) | Peer reviewed | Published
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis.
Keller CW, Ruck T, McHugh D, Pfeuffer S, Gross CC, Korsukewitz C, Melzer N, Klotz L, Meuth SG, Münz C, Nimmerjahn F, Wiendl H, Lünemann JD (2019)
In: Annals of Clinical and Translational Neurology, 6(12), 2586-2594. doi:10.1002/acn3.50935
Research article (journal) | Peer reviewed | Published
Influence of Clinical Parameters and Anticoagulation on Intraprocedural Cerebral Microembolic Signals during Pulmonary Vein Isolation
Larbig R, Dittrich R, Kochhaeuser S, Leitz P, Guener F, Korsukewitz C, Dechering D, Pott C, Wasmer K, Schmitges J, Kerckhoff M, Eckardt L, Moennig G (2016)
In: PloS one, 11(6). doi:10.1371/journal.pone.0157886
Research article (journal) | Peer reviewed | Published
Prothrombin and Factor X Are Elevated in Multiple Sclerosis Patients
Goebel K, Kraft P, Pankratz S, Gross CC, Korsukewitz C, Kwiecien R, Mesters R, Kehrel BE, Wiendl H, Kleinschnitz C, Meuth SG (2016)
In: Annals of Neurology, 80(6), 946-951. doi:10.1002/ana.24807
Research article (journal) | Peer reviewed | Published
Discontinuous versus continuous weaning in stroke patients
Teismann I., Oelschläger C., Werstler N., Korsukewitz C., Minnerup J., Ringelstein E., Dziewas R. (2015)
In: Cerebrovascular Diseases, 39(null), 269-277. doi:10.1159/000381222
Research article (journal) | Peer reviewed | Published
Show all publications (10)